Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer

References

Page 1

	Year	Citations
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman, JNCI Journal of the National Cancer Institute	1993	15.4K
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano JAMA	2011	2.9K
Interpreting the significance of changes in health-related quality-of-life scores. David Osoba, George Rodrigues, James D. Myles, Journal of Clinical Oncology	1998	2.9K
EORTC QLQ-C30 Scoring Manual Peter Fayers, Neil K. Aaronson, Kristin Bjordal, Research at the University of Copenhagen (University of Copenhagen)	1995	2.4K
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases Armando E. Giuliano, Linda McCall, Peter D. Beitsch, Annals of Surgery	2010	1.2K
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. Mirjam A. G. Sprangers, M. Groenvold, Juan Ignacio Arrarás, Journal of Clinical Oncology	1996	1.2K
Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011 Anthony Lucci, Linda McCall, Peter D. Beitsch, Journal of Clinical Oncology	2007	893
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study Ethan Basch, Alexia Iasonos, Tiffani L. McDonough, The Lancet Oncology Adverse EventsAdverse EventMedicineEpidemiology Of CancerPatient Safety	2006	646
Morbidity After Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results From a Randomized Controlled Trial Sara Upponi, Manfred Klevesath, Lynda G. Bobrow, Journal of Clinical Oncology	2005	522
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer Anne Fleissig, Lesley Fallowfield, C. Langridge, Breast Cancer Research and Treatment Surgical OncologyBreast OncologyEarly Breast CancerMedicineCancer Management	2005	493

Page 1